US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Cleo Diagnostics Ltd (COV) 銘柄情報

Cleo Diagnostics Ltd (COV)

0.51

-0.01

(-1.92%)

終了 6月10日 3:00PM

Cleo Diagnostics Ltd (COV) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.51

( -1.92% )

買値

0.49

売値

0.525

出来高

73,618

0.50 日の範囲 0.51

0.335 52 週間の範囲 0.90

時価総額

前日終値

0.52

始値

0.51

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 169,467

発行済株式数

136,862,085

配当利回り

PER

-16.42

1 株当たり利益 (EPS)

-0.03

歳入

2.56M

純利益

-4.03M

Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determi... Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.cleodx.com

本社

Melbourne, Australia

設立

2026

Cleo Diagnostics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker COV. The last closing price for Cleo Diagnostics was AUD0.52. Over the last year, Cleo Diagnostics shares have traded in a share price range of AUD 0.335 to AUD 0.90.

Cleo Diagnostics currently has 136,862,085 shares in issue. The market capitalisation of Cleo Diagnostics is AUD69.80 million. Cleo Diagnostics has a price to earnings ratio (PE ratio) of -16.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.055	-9.73451327434	0.565	0.565	0.5	69699	0.52860095	DE
4	-0.18	-26.0869565217	0.69	0.7	0.5	150223	0.61160409	DE
12	0.035	7.36842105263	0.475	0.75	0.4575	167011	0.59203826	DE
26	-0.14	-21.5384615385	0.65	0.9	0.4575	245464	0.6302497	DE
52	0.155	43.661971831	0.355	0.9	0.335	210260	0.55503692	DE
156	0.28	121.739130435	0.23	0.9	0.14	169086	0.43238344	DE
260	0.28	121.739130435	0.23	0.9	0.14	169086	0.43238344	DE

COV - Frequently Asked Questions (FAQ)

What is the current Cleo Diagnostics Ltd share price?

The current share price of Cleo Diagnostics Ltd is AUD 0.51

How many Cleo Diagnostics Ltd shares are in issue?

Cleo Diagnostics Ltd has 136,862,085 shares in issue

What is the market cap of Cleo Diagnostics Ltd?

The market capitalisation of Cleo Diagnostics Ltd is AUD 69.8M

What is the 1 year trading range for Cleo Diagnostics Ltd share price?

Cleo Diagnostics Ltd has traded in the range of AUD 0.335 to AUD 0.90 during the past year

What is the PE ratio of Cleo Diagnostics Ltd?

The price to earnings ratio of Cleo Diagnostics Ltd is -16.42

What is the cash to sales ratio of Cleo Diagnostics Ltd?

The cash to sales ratio of Cleo Diagnostics Ltd is 27.51

What is the registered address of Cleo Diagnostics Ltd?

The registered address for Cleo Diagnostics Ltd is 480 Collins Street, Melbourne, Victoria, 3000

What is the Cleo Diagnostics Ltd website address?

The website address for Cleo Diagnostics Ltd is www.cleodx.com

CaptHowdy

CaptHowdy 4分前

Correct, now Im just flipping the $6 to $8 range that this POS remains stuck in.
As stated in previous post, FLIP IT... I clearly said I'm not an investor... the bloated salaries will never allow them to become a profitable company. Reading IS fundamental 📚

nsomniyak

nsomniyak 8分前

That’s my take as well

dinogreeves

dinogreeves 15分前

Nickel off from the low of the day.

rodeoup

rodeoup 19分前

One of the biggest compliments an investor can get is when any member of the non investing Basher Cartel says you have no credibility, total LOL!!!

price_and_volume

price_and_volume 22分前

Cesspool with same posters. Have fun over there...
I will look into other stock boards...maybe stocktwits. Do you post on every stock you own?

Is it that important or interesting to do so?

Just curious why this one means so much to anyone.

CA Market News

CA Market News 22分前

Ynvisible Reports Customer Deliveries and Continued Commercial Execution in First Five Months of 2026June 10, 2026 2:00 AM
NewsfileVanc

price_and_volume

price_and_volume 25分前

Where'd you get this nonsense?
Craig was named 'CEO' of GBT Where, when, and by whom was Marshak named "CEO of $GTCH"?

Post a link where you got your info please.

Here's ALL the filings:

https://www.sec.gov/edgar/browse/?CIK=1471781

rbtree

rbtree 30分前

Check back in six months or a year.

CorsairPirate8

CorsairPirate8 33分前

DFTT
Please don't feed the (Lazer) Troll

US Market News

US Market News 37分前

Europe’s Payments Leaders Gather in London as Control, Fraud and AI Reshape the IndustryJune 10, 2026 2:00 AM
Business Wire Executives from ACI Worldwide, Mastercard, Santander, Amazon, NVIDIA and PayPal to debate the future of money at Payments Unleashed EMEA As Europe

MadBrewer

MadBrewer 39分前

😆Caught that😆
Like I said, I've been nipping at this for a bit; 100-150k here & there but,
realized I've grown enough here that I may have to re-consider
how I position my troops.

Cheers

Seminole Red

Seminole Red 49分前

many New good golfers to watch for

SteveSchiets

SteveSchiets 50分前

From what i know about lwlg, news isn’t coming out before Q3/Q4. Spacex is draining liquidity from the market. Could be ruff. Will see

krab

Correct, implemented by that good for nothing thief BO

Truenorth2016

Truenorth2016 54分前

" I playes that timing game"...My bad typo, meant to say "I Played"...

Wolf-man jack

Wolf-man jack 57分前

WQLF SAYS: From Three months ago YQU Understand. Have Mercy WQLF ahoooooo

250211 The Reg & Macro Outlook for U.S. CBD #hempindustry #cbd .

Co-Founder & Board Member, Charlotte's Web Joseph Dowling, CEO, CV Sciences John Harloe, General Counsel, Village Farms...

Wolf-man jack

Wolf-man jack 60分前

WQLFPACK + 🐺Plus🦊Cbd NEWS 📰
June 10, 2026 1st Edition T@Yahooo

WQLF SAYS : Enjoy the 🐻 Charlottes 🕷️ Web Message Board NEWS 🗞️ YQU Understand..Have Mercy WQLF ahoooooo

250211 The Reg & Macro Outlook for U.S. CBD #he

MadBrewer

MadBrewer 1時間前

Same boat,..
More heavy in twoh but the more I see in biei,
the more I'm wondering if I stumbled into something better.

I'm just wondering which hits first;-)

Cheers

Achilles deFlandres

Achilles deFlandres 1時間前

There are multitudes of powers and duties assigned to FHFA, this one is most relevant to your statement: Under HERA 122 STAT 2738 >>(J) Incidental Powers --INCIDENTAL POWERS.—The Agency may, as conservator or receiver—>>....>> ‘(ii) take any action authorized by this section, which the Agency deter

midastouch017

midastouch017 1時間前

As i previously wrote:
RDHL- a shlimazal company.

Truenorth2016

Truenorth2016 1時間前

I'm not willing to risk getting caught "without".

Exactly why I been here nonstop waiting for news. I playes that timing game with many of plays and always missed the run when it finally started to run while I was out and about, running errands, not in front of computer, etc. Best to

Wolf-man jack

Wolf-man jack 1時間前

WQLF SAYS: In other words, Charlottes Web was chosen for the Medicare Pilot Program because of the new BAT / CWBHF Director's Connection to the POTUS, and not on the merit of their Products. Now it makes sense why MMJ International was suing the CMS for choosing Charlottes Web because their produc

knrorrel

knrorrel 1時間前

PAVS strong oversold, on watch today , round 2 , great website, strong increase in sales
https://pavs.ai/
imho

knrorrel

knrorrel 1時間前

$PAVS strong oversold, on watch today , round 2 , great website, strong increase in sales
https://pavs.ai/
imho

Helter Skelter

Helter Skelter 1時間前

AI Overview 👉️ Yes, Malikie Innovations had a patent infringement case against Vantiva (formerly Technicolor) regarding Wi-Fi/wireless standard-essential patents (SEPs). The dispute was administratively closed and resolved via a negotiated settlement on March 9, 2026.

Cleo Diagnostics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。